Monitoring disease progression in follicular lymphoma with next-gen sequencing

Nathanael S Gray

MALT1 inhibitors for the treatment of chemo-resistant ABC-DLBCL

Non-Hodgkin lymphoma

Pathology

Suzanne McGoldrick

Burkitt Lymphoma Clinical Care Project

Non-Hodgkin lymphoma

Pathology

Sam Mbulaiteye

non-AIDS Lymphomas

Non-Hodgkin lymphoma

Hematology and hematologic malignancies Pathology Pediatric oncology or childhood cancer

Dean W Felsher

Prognostic Metabolic Signatures of Cancers Through Mass Spectrometry Imaging

Non-Hodgkin lymphoma Liver and intrahepatic bile ducts Hodgkin lymphoma

Hematology and hematologic malignancies

Anneclaire J De Roos

Occupational Pesticide Use and Risk of Lymphoid Cancers

Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases Leukaemia

Nathaniel Rothman

DDT, PCBs, and Other Persistent Organohalide Chemicals in the JANUS Cohort

Trachea, bronchus and lung Thyroid Testis Prostate Pancreas Ovary Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases Lip, oral cavity Leukaemia

Hematology and hematologic malignancies Pathology

Saro Armenian

Anthraycline-Related Cardiotoxicity in Long-Term Survivors of Lymphoma

Non-Hodgkin lymphoma Hodgkin lymphoma

Hematology and hematologic malignancies Pediatric oncology or childhood cancer

Elaine Jaffe

Lymphoma Disease Discovery and Definition

Non-Hodgkin lymphoma

Hematology and hematologic malignancies Pathology

Michael Wang

A Phase II, Multicenter, International Study of Lenalidomide and Rituximab in Relapsed/Refractory Mantle Cell Lymphoma, Diffuse Large B-Cell Non-Hodgkin Lymphoma, Transformed Large Cell Lymphoma, and Grade 3 Follicular Lymphoma

Non-Hodgkin lymphoma

Hematology and hematologic malignancies Pathology